We are live on ! Find out more
ENZN

ENZON PHARMACEUTICALS INC
ENZN

Delisted

ENZN was delisted on the 19th of May, 2016.

Back to rankings

1 hedge funds and large institutions have $10K invested in ENZON PHARMACEUTICALS INC in 2018 Q2 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 1 → 1 (0)

0% more capital invested

Capital invested by funds: $10K → $10K ($0)

Holders
1
Holders Change
–
Holders Change %
0%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
PAM
1
Panagora Asset Management
Massachusetts
$10K – – –

ENZN Hedge Fund Activity: Q2 2018 in Review

1 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in ENZON PHARMACEUTICALS INC (ENZN) for Q2 2018, worth a combined $10K — unchanged from a quarter earlier.

Fund positioning in ENZN was balanced in Q2 2018: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

  • 1 institutional investor held ENZON PHARMACEUTICALS INC (ENZN) as of Q2 2018, unchanged from Q1 2018.
  • Funds reported $10K of ENZON PHARMACEUTICALS INC stock for Q2 2018, unchanged quarter-over-quarter.
  • 0 funds opened new ENZON PHARMACEUTICALS INC positions in Q2 2018 and 0 closed out.

Based on aggregated 13F filings for Q2 2018.